SCHEMBL3123341

SCHEMBL3123341

COc1ccc(-c2ccc(=O)[nH]n2)c2nc(C(F)(F)F)nn12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 14/20 0.56
PDE4B Q07343 14/20 0.56
LMNA P02545 3/20 0.39
PDE3B Q13370 3/20 0.36
PDE4A P27815 3/20 0.36
PDE4C Q08493 3/20 0.36
PDE4D Q08499 3/20 0.36
CYP1A2 P05177 2/20 0.34
TP53 P04637 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C19 P33261 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HRH3 Q9Y5N1 2/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13326898 0.82 PDE3A (0.56) PDE3APDE4BLMNAPDE3BPDE4A
SCHEMBL2960853 0.80 PDE4B (0.69) PDE3APDE4B
SCHEMBL3122172 0.77 PDE4B (0.55) PDE3APDE4BHPGDPDE5A
SCHEMBL3119039 0.73 PDE4B (0.48) PDE3APDE4BPDE4APDE4CPDE4D
SCHEMBL2957010 0.72 PDE4B (1.00) PDE3APDE4BLMNAPDE3BPDE4A
SCHEMBL3120341 0.71 PDE4B (1.00) PDE3APDE4B
SCHEMBL2172803 0.71 PDE4B (0.52) PDE3APDE4BKMT2A
SCHEMBL2844148 0.70 PDE4B (0.49) PDE3APDE4BKMT2A
SCHEMBL2843134 0.66 PDE4B (0.47) PDE3APDE4B
SCHEMBL2846506 0.65 PDE4B (0.42) PDE3APDE4BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160335-A1 PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT KYORIN PHARMACEUTICAL CO., LTD. 2010-06-24 US disclosed
US-20100160335-A1 PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT KYORIN PHARMACEUTICAL CO., LTD. 2010-06-24 US disclosed
EP-2168959-A1 PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT Kyorin Pharmaceutical Co., Ltd. (JP) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160335-A1 PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT PDE3A, PDE5A, PDE2A PDE3A 1/4885PDE4B 8/4885LMNA 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.